Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
about
COPD exacerbations. 4: PreventionImpact of bronchodilator therapy on exercise tolerance in COPD.Oxygen kinetics and debt during recovery from expiratory flow-limited exercise in healthy humans.Review of guidelines and the literature in the treatment of acute bronchospasm in chronic obstructive pulmonary disease.Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.A human model of the pathophysiology of chronic obstructive pulmonary disease.COPD: what is the unmet need?Exercise dyspnea in patients with COPDEffects of non-invasive ventilation and posture on chest wall volumes and motion in patients with amyotrophic lateral sclerosis: a case series.An assessment of pulmonary function testing and ventilatory kinematics by optoelectronic plethysmography.Responsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPD.Factors limiting exercise tolerance in chronic lung diseases.Dynamics of chest wall volume regulation during constant work rate exercise in patients with chronic obstructive pulmonary disease.Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?Assessing the exercise response to a bronchodilator in COPD: time to get off your bike?Ventilatory and sensory responses in adult survivors of preterm birth and bronchopulmonary dysplasia with reduced exercise capacity.The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles vs. lower limb muscle dysfunction vs. dynamic hyperinflation. Defining 'dynamic hyperinflation'.The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.The Effect of Benign and Malignant Pleural Disease on Chest Wall Mechanics.Heliox increases quadriceps muscle oxygen delivery during exercise in COPD patients with and without dynamic hyperinflation.Inhaled Beta Agonist Bronchodilator Does Not Affect Trans-diaphragmatic Pressure Gradient but Decreases Lower Esophageal Sphincter Retention Pressure in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Gastroesophageal Reflux Disease (Mild Chronic Obstructive Pulmonary Disease Does Exist-and Affects Gas Exchange during Exercise.Limitation in tidal volume expansion partially determines the intensity of physical activity in COPD.CPAP and EPAP elicit similar lung deflation in a non-equivalent mode in GOLD 3-4 COPD patients.
P2860
Q30480789-1B44FF95-0B39-44DD-9843-4B1C93CF0BA2Q33831434-DD59198B-334B-4333-92C9-C74E2B342CC8Q35610291-B68D1F87-6B1D-4C82-BA03-EB4C407EB86CQ36582706-27267BB7-324B-462E-8406-CDA2B815D9B8Q36636050-610A03CE-E383-4C36-900B-0370833671C9Q36857554-019DD7CC-61B0-455A-954C-52803E652DB6Q36964961-88EF2E02-A8C2-4CEA-9E3D-B802A5428769Q37082566-7160D2A5-42C1-4DD4-BFE0-ED593F51AB25Q37241454-F39EBDBB-E7F9-482F-87C5-3A23BFA12E41Q37902711-00595F48-A1FD-470A-BE98-C8F55EFBBAB9Q38083660-58DFB527-5750-4B9F-AE01-A3160F0221C3Q38110749-A5456BD5-7C8D-4963-B51E-E121BADFB0DAQ41842925-77371B58-D972-4283-8A99-BE1BCE2996C6Q42000096-E47461B4-0B22-4EE2-809E-39922753CCBEQ42733325-AC9BD1D2-5850-47B0-A63A-41937EEACCEFQ43987447-699816D2-E8CE-47FB-908E-998D2565F10FQ46283612-7F0ABC90-6F09-4E5F-B23D-2BD958FD3F24Q46528034-4122F63C-856C-4C8D-9A9D-341164B28DE8Q47833608-10DE7982-4B86-4D3D-92FE-C0AEAD9D9072Q50492368-C0BD549B-FD8A-49B8-B58B-6384CD5E0C6AQ51500798-747A9A26-92BB-495D-90AA-63FCD6119FB0Q51621893-F8B7FE8C-D6E2-40D7-B233-31EDCE40F702Q51683952-4FA0DC9F-109E-4844-8F1D-CA044FF52003Q51806623-71C65176-50F9-4E83-9FF0-B8E93134F886
P2860
Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Effect of salbutamol on lung f ...... t and during exercise in COPD.
@ast
Effect of salbutamol on lung f ...... t and during exercise in COPD.
@en
type
label
Effect of salbutamol on lung f ...... t and during exercise in COPD.
@ast
Effect of salbutamol on lung f ...... t and during exercise in COPD.
@en
prefLabel
Effect of salbutamol on lung f ...... t and during exercise in COPD.
@ast
Effect of salbutamol on lung f ...... t and during exercise in COPD.
@en
P2093
P2860
P356
P1433
P1476
Effect of salbutamol on lung f ...... t and during exercise in COPD.
@en
P2093
A Aliverti
A Lo Mauro
N Stevenson
P M A Calverley
R L Dellacà
P2860
P304
P356
10.1136/THX.2004.037937
P407
P577
2005-06-30T00:00:00Z